Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sodium Valproate 333mg + Valporic Acid 145mg Tablet
Therapeutic Category
Neurology, Antiepileptic
Dosage Form
Tablet
Packaging Type
Alu Strip
Packaging
10*10
Price
₹99/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Sodium Valproate 333mg + Valproic Acid 145mg tablet is an extended-release antiepileptic formulation used for the effective management of seizure disorders and epilepsy, providing prolonged therapeutic coverage.
It works by stabilizing neuronal electrical activity and enhancing GABA-mediated inhibitory neurotransmission, reducing seizure frequency and controlling abnormal nerve excitability.
This tablet is commonly prescribed for generalized and partial seizures, bipolar disorder, and migraine prevention, offering comprehensive support for neurological conditions.
With proven clinical efficacy, extended-release convenience, and strong prescription acceptance, this formulation strengthens a neurology-focused product portfolio and ensures consistent therapeutic demand.
Common side effects may include nausea, vomiting, dizziness, tremors, weight gain, or mild gastrointestinal discomfort. Rarely, liver dysfunction, pancreatitis, or thrombocytopenia may occur; regular monitoring is recommended during prolonged therapy.
Valpotime CR 500 Tablet is indicated for the management of epilepsy, including generalized and partial seizures, bipolar disorder, and migraine prophylaxis, as prescribed by a healthcare professional.
For oral use only. Use strictly under medical supervision. Do not discontinue treatment abruptly. Inform your doctor about any liver, kidney, or metabolic disorders prior to use.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
Composition : Sodium Valproate I.P. 133mg + Valproic Acid I.P. 58mg (C.R.)
Composition : Sodium Valproate 200mg + Valproic Acid 87mg
Composition : Pregabalin (150mg)
Composition : Pregabalin (300mg) Capsule
Composition : Pregabalin I.P. 50mg + Duloxetine 20mg
Composition : Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg
Composition : Pregabalin-75mg + Duloxetine 30mg Caps (Delayed Release)
Composition : Pregabalin (75mg) + Etoricoxib (60mg)
Composition : Pregabalin (75mg) + Nortriptyline (10mg)
Composition : Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg) + Vitamin D3 (2000IU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Valpotime CR 500 Tablet has strong demand in the neurology, psychiatry, and central nervous system (CNS) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neurological and mental healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for neurological and mood disorder management under specialist supervision. Sodium Valproate 333mg + Valproic Acid 145mg (Controlled Release) is a well-established anticonvulsant and mood-stabilizing combination Commonly prescribed for the management of epilepsy, seizure disorders, bipolar disorder, and migraine prophylaxis as advised by healthcare professionals Controlled-release formulation helps provide sustained drug release and supports long-term treatment adherence Helps control abnormal electrical activity in the brain and assists in maintaining neurological stability Higher-strength formulation may be utilized according to physician-directed treatment requirements Frequently utilized in neurology clinics, psychiatry centers, hospitals, and specialty healthcare facilities Widely prescribed by neurologists and psychiatrists This strengthens a comprehensive CNS and neurological care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Valpotime CR 500 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand, long-term therapy requirements, repeat purchases, reliable supply chain support, and attractive margins in the neurology and psychiatry segment.
How can I become a distributor or franchise partner for this product?